dr. michael rotkowitz on dacarbazine plus ipilimumab in patients with metastatic melanoma
Published 12 years ago • 238 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:08
dr. michael rotkowitz on ipilimumab plus dacarbazine for metastatic melanoma
-
0:48
dr. michael rotkowitz on the dabrafenib plus trametinib combination for melanoma
-
0:38
dr. hoos on the ipilimumab plus dacarbazine combination trial
-
1:28
dr. michael rotkowitz on the benefits of targeted therapies
-
4:58
treatment choices in metastatic melanoma
-
6:04
explaining therapeutic options to patients with advanced melanoma
-
0:58
dr. antoni ribas on combining vemurafenib and ipilimumab for metastatic melanoma
-
1:40
melanoma patient debbie tells us how dabrafenib has given her hope
-
1:01:30
dermatopathology: vasculitis, vasculopathy & more
-
36:04
melanoma and brain metastases
-
1:19
eribulin versus dacarbazine in patients with leiomyosarcoma and adipocytic sarcoma
-
2:01
dr. sondak on ipilimumab in the adjuvant setting for melanoma
-
3:19
safety and efficacy of increased ipilimumab dosage in metastatic melanoma
-
0:44
dr. michael rotkowitz on dabrafenib and trametinib combination side effects
-
1:29
dr. george demetri on the mutagenic properties and future potentials of dacarbazine
-
0:54
dr. michael a. davies on identifying patients with melanoma at risk for developing brain metastases
-
1:40
immunosarc2: doxorubicin and dacarbazine with nivolumab in leiomyosarcoma
-
3:56
interview dr patrick schöffski asco 2015
-
2:23
dr. michael atkins on immunotherapy or targeted therapy as first treatment for advanced melanoma
-
1:28
immunotherapy versus targeted therapy for advanced melanoma
-
0:55
rajni kannan on managing the side effects of ipilimumab and vemurafenib
-
1:11
chemotherapy for melanoma - why is it not effective and what is its future?